The risky cocktail: What combination effects can we expect between ecstasy and other amphetamines?

Archives of Toxicology

Volumn 87, Issue 1, 2013, Pages 111-122

  Da Silva, Diana Dias ^a,b,d   Carmo, Helena ^c   Silva, Elisabete ^d  

^a University of Porto   (Portugal)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF PORTO   (Portugal)

^d BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

3,4 methylenedioxymethamphetamine (ecstasy, MDMA); Amphetamine related toxicity; Combination effects; Concentration addition (CA); Hepatocytes; Independent action (IA)

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 METHYLTHIOAMPHETAMINE; AMPHETAMINE DERIVATIVE; DEXAMPHETAMINE; METHAMPHETAMINE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HEPATOMA CELL; HUMAN; HUMAN CELL; METABOLISM; PREDICTION; PRIORITY JOURNAL;

AMPHETAMINES; CELL LINE; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG SYNERGISM; HUMANS; METHAMPHETAMINE; MODELS, THEORETICAL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; REGRESSION ANALYSIS; STREET DRUGS;

EID: 84872301466     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-012-0929-9     Document Type: Article

References (62)

1. Altenburger R, Backhaus T, Boedeker W, Faust M, Scholze M, Grimme LH (2000) Predictability of the toxicity of multiple chemical mixtures to Vibrio fisheri: mixtures composed of similarly acting chemicals. Environ Toxicol Chem 19(9):2341-2347
2. Backhaus T, Altenburger R, Boedeker W, Faust M, Scholze M, Grimme LH (2000a) Predictability of the toxicity of a multiple mixture of dissimilarly acting chemicals to Vibrio fischeri. Environ Toxicol Chem 19(9):2348-2356
3. Backhaus T, Scholze M, Grimme LH (2000b) The single substance and mixture toxicity of quinolones to the bioluminescent bacterium Vibrio fischeri. Aquat Toxicol 49(1-2):49-61
4. Barbosa DJ, Capela JP, Oliveira JM et al (2012) Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes. Br J Pharmacol 165(4b):1017-1033. doi:10.1111/j.1476-5381.2011. 01453.x
5. Barrett SP, Darredeau C, Pihl RO (2006) Patterns of simultaneous polysubstance use in drug using university students. Hum Psychopharmacol Clin 21(4):255-263. doi:10.1002/Hup.766
6. Becker J, Neis P, Rohrich J, Zorntlein S (2003) A fatal paramethoxymethamphetamine intoxication. Leg Med (Tokyo) 5(Suppl 1): S138-S141
7. Bliss CI (1939) The toxicity of poisons applied jointly. Ann Appl Biol 26:585-615
8. Camilleri AM, Caldicott D (2005) Underground pill testing, down under. Forensic Sci Int 151(1):53-58. doi:10.1016/J.Forsciint. 2004.07.004
9. Capela JP, Meisel A, Abreu AR et al (2006) Neurotoxicity of ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. J Pharmacol Exp Ther 316(1):53-61. doi:10.1124/jpet. 105.092577
10. Carmo H, Hengstler JG, de Boer D et al (2004) Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse. Naunyn Schmiedebergs Arch Pharmacol 369(2):198-205. doi: 10.1007/S00210-003-0850-0
11. Carvalho M, Hawksworth G, Milhazes N et al (2002) Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells. Arch Toxicol 76(10):581-588. doi:10.1007/S00204- 002-0381-3
12. Carvalho M, Remiao F, Milhazes N et al (2004a) The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine. Toxicology 200(2-3):193-203. doi:10.1016/j.tox.2004.03.016
13. Carvalho M, Remiao F, Milhazes N et al (2004b) Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro. Chem Res Toxicol 17(5):623-632. doi:10.1021/tx049960f
14. Carvalho M, Pontes H, Remiao F, Bastos ML, Carvalho F (2010) Mechanisms underlying the hepatotoxic effects of ecstasy. Curr Pharm Biotechnol 11(5):476-495
15. Carvalho M, Carmo H, Costa VM et al (2012) Toxicity of amphetamines: an update. Arch Toxicol. doi:10.1007/s00204-012-0815-5
16. Chen Q, Cederbaum AI (1997) Menadione cytotoxicity to Hep G2 cells and protection by activation of nuclear factor-kappaB. Mol Pharmacol 52(4):648-657
17. Clemens KJ, Cornish JL, Li KM, Hunt GE, McGregor IS (2005) MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. Neuropharmacology 49(2):195-207. doi: 10.1016/j.neuropharm.2005.03.002
18. Cloonan SM, Keating JJ, Corrigan D et al (2010) Synthesis and in vitro toxicity of 4-MTA, its characteristic clandestine synthesis byproducts and related sulfur substituted alpha-alkylthioamphetamines. Bioorg Med Chem 18(11):4009-4031. doi:10.1016/J.Bmc.2010.04.022
19. Custodio JBA, Santos MS, Goncalves DIR et al (2010) Comparative effects of 3,4-methylenedioxymethamphetamine and 4-methylthioamphetamine on rat liver mitochondrial function. Toxicology 270(2-3):99-105. doi:10.1016/J.Tox.2010.01. 022
20. da Silva DG, de Pinho PG, Pontes H et al (2010) Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine. J Chromatogr, B: Anal Technol Biomed Life Sci 878(9-10):815-822. doi:10.1016/j.jchromb.2010.01. 042
21. Darroudi F, Meijers CM, Hadjidekova V, Natarajan AT (1996) Detection of aneugenic and clastogenic potential of X-rays, directly and indirectly acting chemicals in human hepatoma (Hep G2) and peripheral blood lymphocytes, using the micronucleus assay and fluorescent in situ hybridization with a DNA centromeric probe. Mutagenesis 11(5):425-433
22. de la Torre R, Farre M, Navarro M, Pacifici R, Zuccaro P, Pichini S (2004) Clinical pharmacokinetics of amfetamine and related substances -monitoring in conventional and non-conventional matrices. Clin Pharmacokinet 43(3):157-185
23. De Letter EA, Coopman VAE, Cordonnier JACM, Piette MHA (2001) One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings. Int J Legal Med 114(6):352-356
24. De Letter EA, Bouche MP, Van Bocxlaer JF, Lambert WE, Piette MH (2004) Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities. Forensic Sci Int 141(2-3):85-90. doi: 10.1016/j.forsciint.2003.12.015
25. De Letter EA, Piette MHA, Lambert WE, Cordonnier JACM (2006) Amphetamines as potential inducers of fatalities: a review in the district of Ghent from 1976-2004. Med Sci Law 46(1):37-65
26. Donato MT, Lahoz A, Castell JV, Gomez-Lechon MJ (2008) Cell lines: a tool for in vitro drug metabolism studies. Curr Drug Metab 9(1):1-11
27. Doostdar H, Grant MH, Melvin WT, Wolf CR, Burke MD (1993) The effects of inducing agents on cytochrome P450 and UDPglucuronyltransferase activities in human HEPG2 hepatoma cells. Biochem Pharmacol 46(4):629-635
28. Drescher K, Boedeker W (1995) Assessment of the combined effects of substances -the relationship between concentration addition and independent action. Biometrics 51(2):716-730
29. Elliott SP (2000) Fatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA). J Anal Toxicol 24(2): 85-89
30. Garcia-Repetto R, Moreno E, Soriano T, Jurado C, Gimenez MP, Menendez M (2003) Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose. Forensic Sci Int 135(2):110-114. doi:10.1016/S0379-0738(03)00179-8
31. Hayat S, Williams RJ, Rattray M (2006) Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro. J Psychopharmacol 20(2):257-263. doi:10.1177/0269881106063273
32. Jimenez A, Jorda EG, Verdaguer E et al (2004) Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol Appl Pharm 196(2):223-234. doi:10.1016/J.Taap.2003.12.017
33. Jones AL, Simpson KJ (1999) Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications. Aliment Pharmacol Ther 13(2):129-133
34. Knasmuller S, Mersch-Sundermann V, Kevekordes S et al (2004) Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology 198(1-3):315-328. doi:10.1016/j.tox.2004.02.008
35. Loewe S, Muchnik H (1926) Effect of combinations: mathematical basis of the problem. Arch Exp Pathol Pharmakol 114:313-326
36. Milroy CM (1999) Ten years of 'ecstasy'. J R Soc Med 92(2):68-72
37. Milroy CM, Clark JC, Forrest AR (1996) Pathology of deaths associated with ''ecstasy'' and ''eve'' misuse. J Clin Pathol 49(2): 149-153
38. Mohamed WMY, Ben Hamida S, Cassel JC, de Vasconcelos AP, Jones BC (2011) MDMA: interactions with other psychoactive drugs. Pharmacol Biochem Behav 99(4):759-774. doi:10.1016/J.Pbb.2011.06.032
39. Morefield KM, Keane M, Felgate P, White JM, Irvine RJ (2011) Pill content, dose and resulting plasma concentrations of 3,4- methylendioxymethamphetamine (MDMA)in recreational 'ecstasy' users. Addiction 106(7):1293-1300. doi:10.1111/J.1360-0443.2011. 03399.X
40. Pavlaki MD, Pereira R, Loureiro S, Soares AMVM (2011) Effects of binary mixtures on the life traits of Daphnia magna. Ecotoxicol Environ Saf 74(1):99-110. doi:10.1016/J.Ecoenv.2010.07.010
41. Pavlic M, Schubert B, Libiseller K, Oberacher H (2010) Comprehensive identification of active compounds in tablets by flowinjection data-dependent tandem mass spectrometry combined with library search. Forensic Sci Int 197(1-3):40-47. doi: 10.1016/J.Forsciint.2009.12.019
42. Payne J, Rajapakse N, Wilkins M, Kortenkamp A (2000) Prediction and assessment of the effects of mixtures of four xenoestrogens. Environ Health Perspect 108(10):983-987
43. Pontes H, Sousa C, Silva R et al (2008) Synergistic toxicity of ethanol and MDMA towards primary cultured rat hepatocytes. Toxicology 254(1-2):42-50. doi:10.1016/j.tox.2008.09.009
44. Pontes H, de Pinho PG, Fernandes E et al (2010) Metabolic interactions between ethanol and MDMA in primary cultured rat hepatocytes. Toxicology 270(2-3):150-157. doi:10.1016/J.Tox.2010.02.010
45. Rajapakse N, Ong D, Kortenkamp A (2001) Defining the impact of weakly estrogenic chemicals on the action of steroidal estrogens. Toxicol Sci Off J Soc Toxicol 60(2):296-304
46. Rajapakse N, Silva E, Kortenkamp A (2002) Combining xenoestrogens at levels below individual No-observed-effect concentrations dramatically enhances steroid hormone action. Environ Health Perspect 110(9):917-921
47. Ripp SL, Falkner KC, Pendleton ML, Tamasi V, Prough RA (2003) Regulation of CYP2C11 by dehydroepiandrosterone and peroxisome proliferators: identification of the negative regulatory region of the gene. Mol Pharmacol 64(1):113-122. doi: 10.1124/mol.64.1.113
48. Scholze M, Boedeker W, Faust M, Backhaus T, Altenburger R, Grimme LH (2001) A general best-fit method for concentrationresponse curves and the estimation of low-effect concentrations. Environ Toxicol Chem 20(2):448-457
49. Shenouda SK, Varner KJ, Carvalho F, Lucchesi PA (2009) Metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes. Cardiovasc Toxicol 9(1):30-38. doi:10.1007/S12012-009- 9034-6
50. Sherlock K, Wolff K, Hay AWM, Conner M (1999) Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department. J Accid Emerg Med 16(3):194-197
51. Silva E, Rajapakse N, Kortenkamp A (2002) Something from ''nothing'' -eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ Sci Technol 36(8):1751-1756. doi:10.1021/Es0101227
52. Silva E, Rajapakse N, Scholze M, Backhaus T, Ermler S, Kortenkamp A (2011a) Joint effects of heterogeneous estrogenic chemicals in the E-screen-exploring the applicability of concentration addition. Toxicol Sci 122(2):383-394. doi:10.1093/Toxsci/Kfr103
53. Silva R, Carmo H, Dinis-Oliveira R et al (2011b) In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells. Arch Toxicol 85(4):315-326. doi: 10.1007/S00204-010-0587-8
54. Simantov R, Tauber M (1997) The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells. FASEB J Off Publ Fed Am Soc Exp Biol 11(2):141-146
55. Stumm G, Schlegel J, Schafer T et al (1999a) Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J Off Publ Fed Am Soc Exp Biol 13(9): 1065-1072
56. Stumm G, Schlegel J, Schafer T et al (1999b) Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J 13(9):1065-1072
57. Tang RX, Kong FY, Fan BF et al (2012) HBx activates FasL and mediates HepG2 cell apoptosis through MLK3-MKK7-JNKs signal module. World J Gastroenterol 18(13):1485-1495. doi: 10.3748/Wjg.V18.I13.1485
58. Tanner-Smith EE (2006) Pharmacological content of tablets sold as ''ecstasy'': results from an online testing service. Drug Alcohol Depend 83(3):247-254. doi:10.1016/J.Drugalcdep.2005.11.016
59. Teng SF, Wu SC, Liu CR, Li JH, Chien CS (2006) Characteristics and trends of 3,4-methylenedioxymethamphetamine (MDMA) tablets found in Taiwan from 2002 to February 2005. Forensic Sci Int 161(2-3):202-208. doi:10.1016/J.Forsciint. 2006.03.035
60. Verschraagen M, Maes A, Ruiter B, Bosman IJ, Smink BE, Lusthof KJ (2007) Post-mortem cases involving amphetamine-based drugs in the Netherlands -comparison with driving under the influence cases. Forensic Sci Int 170(2-3):163-170. doi: 10.1016/J.Forsciint.2007.03.030
61. Walubo A, Seger D (1999) Fatal multi-organ failure after suicidal overdose with MDMA, 'Ecstasy': case report and review of the literature. Hum Exp Toxicol 18(2):119-125
62. Wu LT, Schlenger WE, Galvin DM (2006) Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths. Drug Alcohol Depend 84(1):102-113. doi:10.1016/J.Drugalcdep.2006.01.002